{"name":"MEDPOINTE PHARM HLC","slug":"medpointe-pharm-hlc","ticker":"","exchange":"","domain":"medpointepharmhlc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1957-01-01","label":"Niaspan first approved","drug":"Niaspan","drugSlug":"nicotinic-acid","type":"approval","sentiment":"positive"},{"date":"1957-01-01","label":"Nicotinic Acid first approved","drug":"Nicotinic Acid","drugSlug":"niacin","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Niaspan","genericName":"Nicotinic Acid","slug":"nicotinic-acid","indication":"Methylation support","status":"marketed"},{"name":"Hexafluorenium Bromide","genericName":"hexafluronium","slug":"hexafluronium","indication":"Other","status":"marketed"},{"name":"Mebutina","genericName":"MEBUTAMATE","slug":"mebutamate","indication":"Other","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Nicotinic Acid","genericName":"NIACIN","slug":"niacin","indication":"Dietary Vitamin Supplementation","status":"marketed"}]}],"pipeline":[{"name":"Niaspan","genericName":"Nicotinic Acid","slug":"nicotinic-acid","phase":"marketed","mechanism":"Hydroxycarboxylic acid receptor 2","indications":["Methylation support"],"catalyst":""},{"name":"Hexafluorenium Bromide","genericName":"hexafluronium","slug":"hexafluronium","phase":"marketed","mechanism":"Acetylcholinesterase, Acetylcholinesterase, Butyrylcholinesterase","indications":[],"catalyst":""},{"name":"Mebutina","genericName":"MEBUTAMATE","slug":"mebutamate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nicotinic Acid","genericName":"NIACIN","slug":"niacin","phase":"marketed","mechanism":"NAD synthase","indications":["Dietary Vitamin Supplementation","Fluoride Supplementation for Caries Prophylaxis","Remission of prediabetes","Healthspan improvement"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}